<html lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/  dc: http://purl.org/dc/terms/  foaf: http://xmlns.com/foaf/0.1/  og: http://ogp.me/ns#  rdfs: http://www.w3.org/2000/01/rdf-schema#  schema: http://schema.org/  sioc: http://rdfs.org/sioc/ns#  sioct: http://rdfs.org/sioc/types#  skos: http://www.w3.org/2004/02/skos/core#  xsd: http://www.w3.org/2001/XMLSchema# " class=" js"><!--
* PyWebCopy Engine [version 7.0.2]
* Copyright 2020; Raja Tomar
* File mirrored from [https://ir.novavax.com/2022-01-31-Novavax-Submits-Request-to-the-U-S-FDA-for-Emergency-Use-Authorization-of-COVID-19-Vaccine?sf159335945=1]
* At UTC datetime: [2023-06-27 19:32:09.858927]
--><head>
<!-- begin spin_special_output(head_start) -->
<style type="text/css" wd_script_id="featureboxes_style" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">
		.wd_featurebox_icon {
			display: inline;
		}
		.wd_featurebox_icon img {
			vertical-align: middle;
		}
		div.wd_featurebox_group div.wd_tabs_wrapper {
			border: none;
			border-bottom: 1px solid #E1E1E1;
			padding: 0 0 5px 0;
		}
		div.wd_featurebox_group div.wd_featurebox {
			border: none;
			padding: 8px 0 0 0;
		}
		div.wd_featurebox_group li.wd_tab {
			float: none;
			color: #666666;
		}
		div.wd_featurebox_group li.wd_tab-active {
			border: none;
			background-color: transparent;
			color: #000000;
			font-weight: bold;
		}
		div.wd_featurebox_group li.wd_tab-inactive {
			cursor: auto;
		}
	</style>
<script type="text/javascript" src="js/jquery-webdriver.js" wd_script_id="jquery-webdriver.js" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg=="></script>
<script type="text/javascript" src="js/webdriver.js" wd_script_id="webdriver.js" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg=="></script>
<script type="text/javascript" wd_script_id="featurebox_financial_script" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">
			var ir_featurebox = {
				featureboxes: new Array,
				ticker_data: new Array,

				update: function(index, ticker, filer) {
					var item_id = ticker || filer;
					if (!this.featureboxes[index]) {
						this.featureboxes[index] = {
							ticker: ticker,
							filer: filer,
							chart: false,
							size: false
						};
					}

					if (!this.ticker_data[item_id])
						this.ticker_data[item_id] = {};

					if (ticker && webDriver.jQuery("#ir_featurebox_"+index+"-quote").length)
						this.update_quote(index, ticker);

					if (ticker && webDriver.jQuery("#ir_featurebox_"+index+"-chart").length)
						this.update_chart(index, ticker);

					if (ticker && webDriver.jQuery("#ir_featurebox_"+index+"-data").length)
						this.update_data(index, ticker);

					if (filer && webDriver.jQuery("#ir_featurebox_"+index+"-filings").length)
						this.update_filings(index, filer);

					if (webDriver.jQuery("#ir_featurebox_"+index+"-footer").length)
						this.update_labels(index, ticker, filer);
				},

				update_labels: function(index, ticker, filer) {
					var item_id = ticker || filer;
					if (!this.ticker_data[item_id]["labels"]) {
						webDriver.jQuery("#ir_featurebox_"+index+"-footer").html("");
						webDriver.jQuery.getJSON(
							"index.php",
							{
								ajax: "ir_featurebox",
								ticker: ticker,
								filer: filer,
								data: "labels"
							},
							function(data) {
								ir_featurebox.ticker_data[item_id]["labels"] = data;
								ir_featurebox.update_labels(index, ticker, filer);
							}
						);
					} else {
						webDriver.jQuery("#ir_featurebox_"+index+"-footer").html(this.ticker_data[item_id]["labels"].footer);
					}
				}
			};
		</script>
<style type="text/css" wd_script_id="ir_ticker_label_style" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">
				div.wd_ticker_label {
					text-align: right;
					margin: 5px 0;
				}
				div.wd_ticker_label span.wd_exchange {
					color: #999999;
				}

				div.wd_ticker_label span.wd_exchange:after {
					content: ": ";
				}
			</style>
<style type="text/css" wd_script_id="ir_featurebox_quote_style" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">
				div.wd_quote-value {
					margin: 5px 0 0 0;
				}

				div.wd_quote-price {
					display: inline;
					font-weight: bold;
				}

				div.wd_quote-change {
					display: inline;
					margin-left: 1ex;
					padding-left: 15px;
					font-weight: bold;
				}

				div.wd_quote-change:before {
					content: "(";
				}

				div.wd_quote-change:after {
					content: ")";
				}

				div.wd_quote-value-down div.wd_quote-change {
					color: #cc0000;
					background: url(images/webdriver/stockpricedown.gif) left center no-repeat;
				}

				div.wd_quote-value-up div.wd_quote-change {
					color: #00cc00;
					background: url(images/webdriver/stockpriceup.gif) left center no-repeat;
				}
			</style>
<link href="css/wd_wcag.css" type="text/css" rel="stylesheet" wd_script_id="wd_wcag.css">
<link href="thirdparty/font-awesome/css/font-awesome.min.css" type="text/css" rel="stylesheet" wd_script_id="font-awesome.min.css">
<script type="text/javascript" wd_script_id="ir_featurebox_quote_script" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">
				ir_featurebox.update_quote = function(index, ticker) {
					if (!this.ticker_data[ticker]["quote"]) {
						webDriver.jQuery("#ir_featurebox_"+index+"-quote").html('<center><span class="wd_loading_rotate" ><span class="fa-spin fa-fw fa fa-circle-o-notch" style="font-size: 3em;"></span><span class="wd_sr-only">Loading...</span></span></center>');
						webDriver.jQuery.get(
							"index.php",
							{
								ajax: "ir_featurebox",
								ticker: ticker,
								data: "quote"
							},
							function(data) {
								ir_featurebox.ticker_data[ticker]["quote"] = data;
								ir_featurebox.update_quote(index, ticker);
							}
						);
					} else {
						webDriver.jQuery("#ir_featurebox_"+index+"-quote").html(this.ticker_data[ticker]["quote"]);
					}
				}
			</script>
<style type="text/css" wd_script_id="featurebox_financial_style" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">
			div.wd_chart-quote-footer {
				margin: 5px 0 0 0;
				font-size: .75em;
				color: #999999;
			}
		</style>
<script type="text/javascript" src="js/wd_resize.js" wd_script_id="wd_resize.js" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg=="></script>
<script type="text/javascript" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">webDriver.push_jQuery();</script>
<script type="text/javascript" wd_script_id="view_printable_script" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">
	function view_printable() {
		var loc = window.location;
		var sep = (loc.search == "") ? "?" : "&";
		var url = loc.protocol+"//"+loc.host+loc.pathname+loc.search+sep+"printable"+loc.hash;
		window.open(url, "_blank", "");
	}
</script>
<script type="text/javascript" wd_script_id="format_news_script" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">
(function($) {
	webDriver.formatNews = function() {
		var $news = $(this);
		var print_url = $news.attr("wd_print_url");
		$news.find("table").each(function() {
			var $table = $(this);
			var $parent = $table.parent();
			if ($parent.innerWidth() < $table.outerWidth()) {
				if ($parent.hasClass("wd_news_table")) {
					$parent.find(".fullscreen-button").show();
				} else {
					var $btn = $("<button>View News Release Full Screen</button>")
						.addClass("fullscreen-button")
						.on("click", function() {
							if (print_url)
								window.open(print_url, "_blank", "");
							else
								view_printable();
						})
					;

					var $div = $("<div></div>)")
						.addClass("wd_news_table")
						.css("overflow-x", "auto")
						.append($btn)
					;

					$table.replaceWith($div);
					$div.append($table);
				}
			} else {
				if ($parent.hasClass("wd_news_table"))
					$parent.find(".fullscreen-button").hide();
			}
		});
	}
})(webDriver.jQuery);
</script>
<style type="text/css" wd_script_id="toolbar_style" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">
			div.wd_toolbar {
				border-top: 1px solid #cccccc;
				border-bottom: 1px solid #cccccc;
				margin: 15px 0px 15px 0px;
				padding: 5px;
				line-height: 1;
			}
			div.wd_toolbar-page {
				clear: both;
			}
			div.wd_toolbar ul.wd_tools {
				display: inline-block;
				width: 100%;
				margin: 0;
				padding: 5px 0;
			}
			div.wd_toolbar ul.wd_tools li.wd_tool {
				display: block;
				list-style-type: none;
				margin-right: 5px;
				padding: 0;
				float: right;
			}
			span.wd_tool_icon > a:link,
			span.wd_tool_icon > a:visited {
				border-radius: 2px;
				display: inline-block;
				width: 30px;
				height: 30px;
				box-sizing: border-box;
				margin: 0;
				padding: 7px;
				font-size: 16px;
				line-height: 1;
				text-align: center;
				color: #ffffff;
				background-color: #767676;
			} 
			span.wd_tool_icon > a:hover {
				color: #ffffff;
				background-color: #666666;
				text-decoration: none;
			}
			div.wd_toolbar ul.wd_tools li.wd_tool-addthis {
				float: left;
			}
		</style>
<style type="text/css" wd_script_id="template detail:newsfeed_releases:site style" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">.wd_title {
	font-size: 1.3em;
	font-weight: bold;
}
.wd_subtitle {
	font-weight: bold;
}
table.wd_extimagetable {
	border-style: none; 
	border-spacing:0px;
	clear: right; 
	float: right; 
}
td.wd_extimagecell {
	text-align: right; 
	margin: 0px 0px 5px 5px;
	padding:0px;
}
td.wd_extimagecell img {
	padding-left:10px;
	padding-bottom:10px;
	border-style: none; 
}
blockquote.wd_pullquote {
	font-style: italic;
	width:200px;
	margin:0 0 20px 20px;
	line-height: 1.8em;
	float: right;
	clear: right;
}
blockquote.wd_pullquote:before {
	content: "&#8220; ";
	font-size: xx-large;
}
blockquote.wd_pullquote:after {
	content: " &#8221;";
	font-size: xx-large;
	float: right;
}
.fullscreen-button {
	border: 1px solid #d1d1d1;
	background: #e3e3e3 url(images/webdriver/view_full_screen_button_background.png) no-repeat;
	padding: 3px 3px 3px 30px;
	margin: 5px 0px 5px 0px;
	color: #727272;
	width: 220px;
	-moz-border-radius: 3px;
	border-radius: 3px;
	cursor: pointer;
}
.wd_contact {
	margin: 1em 0;
}
.wd_release_data {
	margin: 1em 0;
}
.wd_caption {
	text-align: center;
	font-size: 0.72em;
	font-style: italic;
	margin: 1em 0 0 0;
}
</style>
<script type="text/javascript" nonce="OWFjNmUzNjA1MTY4YjRhMzg3NTY3NjhkNzk2MGNiNGM1NDdlN2UxMg==">webDriver.pop_jQuery();</script>

<!-- end spin_special_output(head_start) -->
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    
<meta name="MobileOptimized" content="width">
<meta name="HandheldFriendly" content="true">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<style>div#sliding-popup, div#sliding-popup .eu-cookie-withdraw-banner, .eu-cookie-withdraw-tab {background: #0779bf} div#sliding-popup.eu-cookie-withdraw-wrapper { background: transparent; } #sliding-popup h1, #sliding-popup h2, #sliding-popup h3, #sliding-popup p, #sliding-popup label, #sliding-popup div, .eu-cookie-compliance-more-button, .eu-cookie-compliance-secondary-button, .eu-cookie-withdraw-tab { color: #ffffff;} .eu-cookie-withdraw-tab { border-color: #ffffff;}</style>
<meta http-equiv="x-ua-compatible" content="ie=edge">
<meta name="twitter:card" content="summary_large_image">
<link rel="icon" type="image/png" href="images/Nvax_favicon_32x32.png" sizes="32x32">


<title>Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine - Jan 31, 2022</title>

 <meta name="keywords" content="">
 <meta name="description" content="">
 <meta name="twitter:card" content="summary">
 <meta name="twitter:title" content="Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine">
 <meta name="twitter:description" content="- NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains GAITHERSBURG, Md., Jan. 31, 2022 /PRNewswire/ -- Novavax, Inc....">
 <meta name="twitter:image" content="https://mma.prnewswire.com/media/1506866/Novavax_High_Res_Logo.jpg?p=twitter">
 <meta property="og:site_name" content="Novavax Investor Relations">
 <meta property="og:url" content="https://ir.novavax.com/2022-01-31-Novavax-Submits-Request-to-the-U-S-FDA-for-Emergency-Use-Authorization-of-COVID-19-Vaccine">
 <meta property="og:title" content="Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine">
 <meta property="og:description" content="- NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains GAITHERSBURG, Md., Jan. 31, 2022 /PRNewswire/ -- Novavax, Inc....">
 <meta name="image" property="og:image" content="https://mma.prnewswire.com/media/1506866/Novavax_High_Res_Logo.jpg?p=facebook">
<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-NXGSZ8G');</script>
<!-- End Google Tag Manager -->
  
    <link rel="stylesheet" href="css/bjz3zry.css">    
    <link rel="stylesheet" media="all" href="css/css_3Qclq2FzANZTVQOw_v4G5j5wF3HxH8XbEY24BhNsDUs.css">
    <link rel="stylesheet" media="all" href="css/css_fkgE5qTsfRAujQkArOAKRXqH9mE1qreyf8npe6GgQeA.css">
<link rel="stylesheet" media="all" href="css/css_SFMFhUVRQlmai0oIcsL_MXhflcvGdneYfvz6d7RDpGY.css">
<link rel="stylesheet" type="text/css" href="css/wdcontent.css">
    
  
<!-- begin spin_special_output(head_end) -->
<link rel="canonical" href="https://ir.novavax.com/2022-01-31-Novavax-Submits-Request-to-the-U-S-FDA-for-Emergency-Use-Authorization-of-COVID-19-Vaccine?sf159335945=1">
<!-- end spin_special_output(head_end) -->
</head>
  <body class="wd_pageid_43 wd_item_page wd_item_338 layout-no-sidebars page-node-296 user-anonymous path-frontpage node--type-nvax-landing-page eu-cookie-compliance-status-null" cz-shortcut-listen="true">
<!-- Google Tag Manager (noscript) -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NXGSZ8G" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->
    <a href="#main-content" class="visually-hidden focusable skip-link">
      Skip to main content
    </a>
    
      <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas="">
    <div id="page-wrapper">
  <div id="page">
    <header id="header" class="header" role="banner" aria-label="Site header">
                      <nav class="navbar navbar-expand-md" id="navbar-main">
                      
                                          </nav>
          </header>
          <div class="highlighted">
        <aside class="container section clearfix" role="complementary">
            <div data-drupal-messages-fallback="" class="hidden"></div>


        </aside>
      </div>
            <div id="main-wrapper" class="layout-main-wrapper clearfix">
              <div id="main" class="container">
          
          <div class="row row-offcanvas row-offcanvas-left clearfix">
              <main class="main-content col" id="content" role="main">
                <section class="section">
                  <a id="main-content" tabindex="-1"></a>
                    <style>.edit__action{padding: 0 5px;}</style>
<div id="block-siteheaderblock" class="block block-nvaxcom-app block-site-header">
      
    
      <div class="content">
                      
<div class="oc-header act-component">
  <div class="oc-header__rgnInner act-component-inner">
  <div class="oc-header__rgnDesktop d-none d-lg-flex">

<ul class="oc-header__rgnMegaNav">
  <li class="oc-header__megaItem nav-item dropdown position-static ">
  <a class="oc-header__megaLink nav-link dropdown-toggle menu-down" href="#" id="j9aIVO" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Science &amp; technology</a>
<div class="oc-header__megaPane dropdown-menu w-100" aria-labelledby="j9aIVO">
  <div class="oc-mmPane act-component">
  <div class="oc-mmPane__rgnInner act-component-inner">
  <div class="oc-mmPane__rgnIntro">
  <div class="oc-mmPane__title">
  <div class="af-text">Science &amp; technology</div>
</div>
<div class="oc-mmPane__body">
  <div class="af-text">
  <p>Novavax creates transformational vaccines that help address some of the world&#8217;s most pressing infectious diseases.</p>
</div>
</div>
</div>
<div class="oc-mmPane__rgnNav">
  <div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/science-technology" aria-label="Overview">Overview</a>
</div>
<div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/science-technology/vaccine-pipeline" aria-label="Our pipeline">Our pipeline</a>
</div>
<div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/science-technology/matrix-m-adjuvant-technology" aria-label="Matrix-M&#8482; adjuvant">Matrix-M&#8482; adjuvant</a>
</div>
<div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology" aria-label="Recombinant protein-based nanoparticle vaccine">Recombinant protein-based nanoparticle vaccine</a>
</div>
<div class="oc-mmPane__navLink globe">
  <a class="af-link" href="https://www.novavax.com/global-vaccine-approval-authorization-map" aria-label="Global vaccine authorization / approval map">Global vaccine authorization / approval map</a>
</div>
</div>
<div class="oc-mmPane__rgnPromo">
  <div class="oc-mmPane__promoImage">
  <img src="images/mm-research.png" alt="COVID-19" class="af-image">
</div>
<div class="oc-mmPane__promoTitle">
  <div class="af-text">COVID-19 UPDATES</div>
</div>
<div class="oc-mmPane__promoBody">
  <div class="af-text">
  <p>Novavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.</p>
</div>
</div>
<div class="oc-mmPane__promoLink">
  <a class="af-link" href="https://www.novavax.com/covid-19-press-releases" aria-label="Learn more about our COVID-19 updates" target="_blank" rel="noopener">Learn more about our COVID-19 updates</a>
</div>
</div>
</div>
</div>
</div>
</li>
<li class="oc-header__megaItem nav-item dropdown position-static ">
  <a class="oc-header__megaLink nav-link dropdown-toggle menu-down" href="#" id="lIMoh5" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Who we are</a>
<div class="oc-header__megaPane dropdown-menu w-100" aria-labelledby="lIMoh5">
  <div class="oc-mmPane act-component">
  <div class="oc-mmPane__rgnInner act-component-inner">
  <div class="oc-mmPane__rgnIntro">
  <div class="oc-mmPane__title">
  <div class="af-text">Who we are</div>
</div>
<div class="oc-mmPane__body">
  <div class="af-text">
  <p>We are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.</p>
</div>
</div>
</div>
<div class="oc-mmPane__rgnNav">
  <div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/who-we-are" aria-label="Our company">Our company</a>
</div>
<div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/who-we-are/leadership#executive-leadership" aria-label="Executive leadership">Executive leadership</a>
</div>
<div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/who-we-are/leadership#senior-management-team" aria-label="Senior management team">Senior management team</a>
</div>
<div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/who-we-are/leadership#board-of-directors" aria-label="Board of directors">Board of directors</a>
</div>
<div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/who-we-are/partners" aria-label="Our partners">Our partners</a>
</div>
</div>
<div class="oc-mmPane__rgnPromo">
  <div class="oc-mmPane__promoImage">
  <img src="images/Main-Nav-Who.png" alt="About us" class="af-image">
</div>
<div class="oc-mmPane__promoTitle">
  <div class="af-text">Build your future with us</div>
</div>
<div class="oc-mmPane__promoBody">
  <div class="af-text">
  <p>Join other passionately curious people who are bringing innovative vaccines to the world</p>
</div>
</div>
<div class="oc-mmPane__promoLink">
  <a class="af-link" href="https://www.novavax.com/careers" aria-label="Discover career opportunities">Discover career opportunities</a>
</div>
</div>
</div>
</div>
</div>
</li>
<li class="oc-header__megaItem nav-item dropdown position-static ">
  <a class="oc-header__megaLink nav-link dropdown-toggle menu-down" href="#" id="sE1cPc" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Insights</a>
<div class="oc-header__megaPane dropdown-menu w-100" aria-labelledby="sE1cPc">
  <div class="oc-mmPane act-component -noPromo">
  <div class="oc-mmPane__rgnInner act-component-inner">
  <div class="oc-mmPane__rgnIntro">
  <div class="oc-mmPane__title">
  <div class="af-text">Insights</div>
</div>
<div class="oc-mmPane__body">
  <div class="af-text">
  <p>Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.</p>
</div>
</div>
</div>
<div class="oc-mmPane__rgnNav">
  <div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/insights" aria-label="Articles">Articles</a>
</div>
<div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/insights/diversity-matters-inclusivity-clinical-trials" aria-label="Diversity matters: Inclusivity in clinical trials">Diversity matters: Inclusivity in clinical trials</a>
</div>
<div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/insights/pandemic-endemic-why-covid-19-may-be-here-stay" aria-label="From pandemic to endemic: Why COVID-19 may be here to stay">From pandemic to endemic: Why COVID-19 may be here to stay</a>
</div>
<div class="oc-mmPane__navLink">
  <a class="af-link" href="https://www.novavax.com/insights/how-novavax-vaccine-developed" aria-label="Standing on the shoulders of giants: How a Novavax vaccine is developed">Standing on the shoulders of giants: How a Novavax vaccine is developed</a>
</div>
</div>
</div>
</div>
</div>
</li>
</ul>
<div class="oc-header__rgnLogo">
  <a href="https://www.novavax.com/home">
  <div class="oc-header__logo">
  <img src="images/novavax-header-logo.svg" alt="Novavax Logo" class="af-image">
</div>
</a>
</div>
<ul class="oc-header__rgnLinkNav">
  <li class="oc-header__linkItem">
  <div class="oc-header__menuLink">
  <a class="af-link" href="https://medical.novavax.com/" aria-label="Medical professionals  ">Medical professionals  </a>
</div>
</li>
<li class="oc-header__linkItem">
  <div class="oc-header__menuLink">
  <a class="af-link" href="https://www.novavax.com/news-and-media" aria-label="News &amp; media">News &amp; media</a>
</div>
</li>
<li class="oc-header__linkItem">
  <div class="oc-header__menuLink">
    <a class="af-link" href="https://ir.novavax.com/investor-hub" aria-label="Investors">Investors</a>
</div>
</li>
<li class="oc-header__linkItem">
  <div class="oc-header__menuLink">
  <a class="af-link" href="https://www.novavax.com/careers" aria-label="Careers">Careers</a>
</div>
</li>
</ul>
</div>
<div class="oc-header__rgnDevice d-flex d-lg-none">
  <nav class="navbar navbar-collapse">
  <div class="navbar-brand oc-header__rgnLogo">
  <a href="https://www.novavax.com/home">
  <div class="oc-header__logo">
  <img src="images/novavax-header-logo.svg" alt="Novavax Logo" class="af-image">
</div>
</a>
</div>
<!-- hamburger icon -->
<button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#mobileMenu" aria-controls="mobileMenu" aria-expanded="false" aria-label="Toggle navigation">
  <span class="navbar-toggler-icon">
  <i class="fas fa-bars menu-open">
</i>
<i class="fas fa-times menu-close">
</i>
</span>
</button>
<!-- menu -->
<div class="collapse navbar-collapse" id="mobileMenu">
  <div class="navbar-container">
  <div class="oc-header__rgnMobileMenu">
  <div class="oc-header__rgnMobileDropNav" id="jmoant">
  <div class="oc-header__dropMenu">
  <div class="oc-header__menuParent">
  <a class="oc-header__dropTrigger" id="s9kq8c" href="#" data-toggle="collapse" data-target="#mdVPuA" aria-expanded="false" aria-controls="mdVPuA">Science &amp; technology</a>
</div>
<div id="mdVPuA" class="oc-header__menuChild collapse" aria-labelledby="s9kq8c" data-parent="#jmoant">
  <div class="oc-header__menuChildInner">
  <div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/science-technology" aria-label="Overview">Overview</a>
</div>
<div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/science-technology/vaccine-pipeline" aria-label="Our pipeline">Our pipeline</a>
</div>
<div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/science-technology/matrix-m-adjuvant-technology" aria-label="Matrix-M&#8482; adjuvant">Matrix-M&#8482; adjuvant</a>
</div>
<div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology" aria-label="Recombinant protein-based nanoparticle vaccine">Recombinant protein-based nanoparticle vaccine</a>
</div>
<div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/global-vaccine-approval-authorization-map" aria-label="Global vaccine authorization / approval map">Global vaccine authorization / approval map</a>
</div>
</div>
</div>
</div>
<div class="oc-header__dropMenu">
  <div class="oc-header__menuParent">
  <a class="oc-header__dropTrigger" id="orcou1" href="#" data-toggle="collapse" data-target="#icPeJ4" aria-expanded="false" aria-controls="icPeJ4">Who we are</a>
</div>
<div id="icPeJ4" class="oc-header__menuChild collapse" aria-labelledby="orcou1" data-parent="#jmoant">
  <div class="oc-header__menuChildInner">
  <div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/who-we-are" aria-label="Our company">Our company</a>
</div>
<div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/who-we-are/leadership#executive-leadership" aria-label="Executive leadership">Executive leadership</a>
</div>
<div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/who-we-are/leadership#senior-management-team" aria-label="Senior management team">Senior management team</a>
</div>
<div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/who-we-are/leadership#board-of-directors" aria-label="Board of directors">Board of directors</a>
</div>
<div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/who-we-are/partners" aria-label="Our partners">Our partners</a>
</div>
</div>
</div>
</div>
<div class="oc-header__dropMenu">
  <div class="oc-header__menuParent">
  <a class="oc-header__dropTrigger" id="cKe2Xt" href="#" data-toggle="collapse" data-target="#hRgPtl" aria-expanded="false" aria-controls="hRgPtl">Insights</a>
</div>
<div id="hRgPtl" class="oc-header__menuChild collapse" aria-labelledby="cKe2Xt" data-parent="#jmoant">
  <div class="oc-header__menuChildInner">
  <div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/insights" aria-label="Articles">Articles</a>
</div>
<div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/insights/diversity-matters-inclusivity-clinical-trials" aria-label="Diversity matters: Inclusivity in clinical trials">Diversity matters: Inclusivity in clinical trials</a>
</div>
<div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/insights/pandemic-endemic-why-covid-19-may-be-here-stay" aria-label="From pandemic to endemic: Why COVID-19 may be here to stay">From pandemic to endemic: Why COVID-19 may be here to stay</a>
</div>
<div class="oc-header__childItem">
  <a class="af-link" href="https://www.novavax.com/insights/how-novavax-vaccine-developed" aria-label="Standing on the shoulders of giants: How a Novavax vaccine is developed">Standing on the shoulders of giants: How a Novavax vaccine is developed</a>
</div>
</div>
</div>
</div>
</div>
<div class="oc-header__rgnMobileLinkNav">
  <div class="oc-header__menuItem">
  <a class="af-link" href="https://medical.novavax.com/" aria-label="Medical professionals  ">Medical professionals  </a>
</div>
<div class="oc-header__menuItem">
  <a class="af-link" href="https://www.novavax.com/news-and-media" aria-label="News &amp; media">News &amp; media</a>
</div>
<div class="oc-header__menuItem">
  <a class="af-link" href="https://ir.novavax.com/investor-hub" aria-label="Investors">Investors</a>
</div>
<div class="oc-header__menuItem">
  <a class="af-link" href="https://www.novavax.com/careers" aria-label="Careers">Careers</a>
</div>
</div>
</div>
</div>
</div>
</nav>
</div>
</div>
</div>
  
      
      

          </div>
  </div>
<style>.edit__action{padding: 0 5px;}</style>
<div id="block-nvaxcom-bootstrap-content" class="block block-system block-system-main-block">
      
    
      <div class="content">
              

<article data-history-node-id="296" role="article" about="/home" class="node node--type-nvax-landing-page node--view-mode-full clearfix">
  <header>
    
        
      </header>
  <div class="node__content clearfix">
    
  <div class="clearfix text-formatted field field--name-field-atomic-render field--type-text-long field--label-hidden field__item">
                  
  
<div class="tpl-landing act-component">
  <div class="tpl-landing__rgnInner act-component-inner">
    <!-- HEADER -->
          <div class="tpl-landing__rgnHero"><div class="mc-heroPane act-component -heroSmall"><div class="mc-heroPane__rgnInner act-component-inner"><div class="mc-heroPane__rgnMain" style="background-image: linear-gradient(180deg, rgba(16,24,85,0.7) 30%, rgba(16,24,85,0) 100%), linear-gradient(180deg, rgba(237,237,237,0) 60%, #EDEDED 100%), url(/image/news-hero.png);"></div></div></div></div>
        <!-- END HEADER -->
    <!-- CONTENT -->
        <div class="tpl-landing__rgnMain">
                      <div class="oc-container -paneDivider wd_inner_header">
          <div class="wd_breadcrumb">News &amp; Media</div>
          <div class="page_header">
            Press releases &amp; statements          </div>
        </div>
                	<div class="oc-container ">

        <div id="wd_printable_content">
<div class="wd_newsfeed_releases-detail">
<div class="wd_title wd_language_left">Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine</div>
<div class="wd_date">Jan 31, 2022</div>





			
		

			
		

<style type="text/css">


/* Style Definitions */
span.prnews_span
{
font-size:8pt;
font-family:"Arial";
color:black;
}
a.prnews_a
{
color:blue;
}
li.prnews_li
{
font-size:8pt;
font-family:"Arial";
color:black;
}
p.prnews_p
{
font-size:0.62em;
font-family:"Arial";
color:black;
margin:0in;
}

				span.prnews_span{
					font-size:inherit;
					font-family:inherit;
				}
				li.prnews_li{
					font-size: inherit;
					font-family: inherit;           
				}
				p.prnews_p{
					font-size: inherit;
					font-family: inherit;           
				}
			
			div.wd_news_body img {
				margin: 0 0 20px 20px;
				float:right;
				max-width: 250px;
				max-height: 250px;
				width: auto !important;
				height: auto !important;
			}
		
				div.PRN_ImbeddedAssetReference{
					display: none;
				}
				div[id^="prni_dvprne"]{
					display: none;
				}
			</style>

<div class="wd_body wd_news_body" wd_resize="formatNews" wd_print_url="https://ir.novavax.com/2022-01-31-Novavax-Submits-Request-to-the-U-S-FDA-for-Emergency-Use-Authorization-of-COVID-19-Vaccine?printable=1">
<p>- <i>NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains</i></p>
<p><span class="xn-location">GAITHERSBURG, Md.</span>, <span class="xn-chron">Jan. 31, 2022</span> /<a href="http://www.prnewswire.com/" target="_blank">PRNewswire</a>/ --&#160;Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced&#160;that it has submitted a request to the U.S Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for NVX-CoV2373, its protein-based COVID-19 vaccine candidate for immunization of individuals 18 year of age and older against SARS-CoV-2.</p>
<p>The request for EUA is based on the totality of pre-clinical, clinical and manufacturing-related (CMC) data provided to the agency, including results of two large pivotal clinical trials that demonstrated an overall efficacy of approximately 90 percent and a reassuring safety profile.</p>
<p>"We're extremely proud of the work of our teams and we look forward to FDA's review of our EUA request. We believe our vaccine offers a differentiated option built on a well-understood protein-based vaccine platform that can be an alternative to the portfolio of available vaccines to help fight the COVID-19 pandemic," said <span class="xn-person">Stanley C. Erck</span>, President and Chief Executive Officer, Novavax. "I'd like to also extend our thanks for the support of the U.S. Department of Health and Human Services and the U.S. Department of Defense for their partnership leading up to today's milestone of EUA request submission."</p>
<p>Novavax conducted two pivotal Phase 3 clinical trials: PREVENT-19 which enrolled approximately 30,000 participants in the U.S. and <span class="xn-location">Mexico</span> and published results in the<i> <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=4185830657&amp;u=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2116185%3Fquery%3Dfeatured_home&amp;a=New+England+Journal+of+Medicine" target="_blank" rel="nofollow">New England Journal of Medicine</a> (NEJM)</i> and a trial with almost 15,000 participants in the U.K. which was also published in <i><a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=889537351&amp;u=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2107659&amp;a=NEJM" target="_blank" rel="nofollow">NEJM</a></i><i>.&#160;</i>In both trials, the vaccine demonstrated efficacy with a reassuring safety profile. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups. The most common adverse reactions observed during clinical studies (frequency category of very common &#8805;1/10) were headache, nausea or vomiting, myalgia, arthralgia, injection site tenderness/pain, fatigue, and malaise. Novavax will continue to collect and analyze real-world data, including the monitoring of safety and the evaluation of variants, as the vaccine is distributed in authorized markets. As part of the PREVENT-19 trial, a booster study is ongoing to evaluate the safety and effectiveness of a third does of the vaccine, as well as a study in adolescents aged 12-17.</p>
<p>NVX-CoV2373 has been granted conditional authorization by multiple regulatory agencies worldwide, including the European Commission, and emergency use listing (EUL) from the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=1252681756&amp;u=https%3A%2F%2Fir.novavax.com%2F2021-12-20-World-Health-Organization-Grants-Second-Emergency-Use-Listing-for-Novavax-COVID-19-Vaccine&amp;a=World+Health+Organization" target="_blank" rel="nofollow">World Health Organization</a> (WHO), with additional filings currently under review.</p>
<p><b>About NVX-CoV2373 <br></b>NVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease. NVX-CoV2373 was created using Novavax' recombinant nanoparticle technology to generate antigen derived from the coronavirus spike (S) protein and is formulated with Novavax' patented saponin-based Matrix-M&#8482; adjuvant to enhance the immune response and stimulate high levels of neutralizing antibodies. NVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19.</p>
<p>Novavax' COVID-19 vaccine is packaged as a ready-to-use liquid formulation in a vial containing ten doses. The vaccination regimen calls for two 0.5 ml doses (5 mcg antigen and 50 mcg Matrix-M adjuvant) given intramuscularly 21 days apart. The vaccine is stored at 2&#176;- 8&#176; Celsius, enabling the use of existing vaccine supply and cold chain channels. Use of the vaccine should be in accordance with official recommendations.</p>
<p>Novavax has established partnerships for the manufacture, commercialization and distribution of NVX-CoV2373 worldwide. Existing authorizations leverage Novavax' manufacturing partnership with Serum Institute of <span class="xn-location">India</span> (SII), the world's largest vaccine manufacturer by volume. They will later be supplemented with data from additional manufacturing sites throughout Novavax' global supply chain.</p>
<p><b>About the NVX-CoV2373 Phase 3 trials <br></b>NVX-CoV2373 is being evaluated in two pivotal Phase 3 trials.</p>
<p>PREVENT-19, a trial in the U.S. and <span class="xn-location">Mexico</span> that enrolled almost 30,000 participants, achieved 90.4% efficacy overall. It was designed as a 2:1 randomized, placebo-controlled, observer-blinded study to evaluate the efficacy, safety and immunogenicity of NVX-CoV2373. The primary endpoint for PREVENT-19 was the first occurrence of PCR-confirmed symptomatic (mild, moderate or severe) COVID-19 with onset at least 7 days after the second dose in serologically negative (to SARS-CoV-2) adult participants at baseline. The statistical success criterion included a lower bound of 95% CI &gt;30%. The key secondary endpoint is the prevention of PCR-confirmed, symptomatic moderate or severe COVID-19. Both endpoints were assessed at least seven days after the second study vaccination in volunteers who had not been previously infected with SARS-CoV-2. It was generally well-tolerated and elicited a robust antibody response after the second dose in both studies. Full results of the trial were published in the <i><a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=4185830657&amp;u=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2116185%3Fquery%3Dfeatured_home&amp;a=New+England+Journal+of+Medicine" target="_blank" rel="nofollow">New England Journal of Medicine</a></i><i> (NEJM).</i></p>
<p>A trial conducted in the U.K. with 14,039 participants was designed as a randomized, placebo-controlled, observer-blinded study and achieved overall efficacy of 89.7%. The primary endpoint was based on the first occurrence of PCR-confirmed symptomatic (mild, moderate or severe) COVID-19 with onset at least 7 days after the second study vaccination in serologically negative (to SARS-CoV-2) adult participants at baseline. Full results of the trial were published in<i> <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=889537351&amp;u=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2107659&amp;a=NEJM" target="_blank" rel="nofollow">NEJM</a></i>.</p>
<p>PREVENT-19 is being conducted with support from the U.S. government, including the Department of Defense, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) at HHS. BARDA is providing up to&#160;$1.75 billion&#160;under a Department of Defense agreement.</p>
<p><b>About Matrix-M&#8482; Adjuvant <br></b>Novavax' patented saponin-based Matrix-M&#8482; adjuvant has demonstrated a potent and generally well-tolerated effect by stimulating the entry of antigen-presenting cells into the injection site and enhancing antigen presentation in local lymph nodes, boosting immune response.</p>
<p><b>About Novavax <br></b>Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company's proprietary recombinant technology platform harnesses the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs. NVX-CoV2373, the company's COVID-19 vaccine, received Conditional Marketing Authorization from the European Commission, Emergency Use Listing from the World Health Organization, Emergency Use Authorization in&#160;Indonesia&#160;and&#160;the <span class="xn-location">Philippines</span>, and has been submitted for regulatory authorization in multiple markets globally.</p>
<p>For more information, visit&#160;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=274133259&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3425721-1%26h%3D1328944201%26u%3Dhttp%253A%252F%252Fwww.novavax.com%252F%26a%3Dwww.novavax.com&amp;a=www.novavax.com" target="_blank" rel="nofollow">www.novavax.com</a>&#160;and connect with us&#160;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=2646657515&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3425721-1%26h%3D1749870132%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fnovavax%252F%26a%3DLinkedIn&amp;a=LinkedIn" target="_blank" rel="nofollow">LinkedIn</a>.</p>
<p><b>Forward-Looking Statements <br></b>Statements herein relating to the future of Novavax, its operating plans and prospects, its partnerships, the ongoing development of NVX-CoV2373, the scope, timing and outcome of future regulatory filings and actions, including Novavax' plans to supplement authorizations with data from the additional manufacturing sites in Novavax' global supply chain, the potential impact of Novavax and NVX-CoV2373 in addressing vaccine access, offering an alternative to existing COVID-19 vaccines, controlling the pandemic and protecting populations, and the efficacy, safety and intended utilization of NVX-CoV2373 are forward-looking statements. Novavax cautions that these forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include challenges satisfying, alone or together with partners, various safety, efficacy, and product characterization requirements, including those related to process qualification and assay validation, necessary to satisfy applicable regulatory authorities; difficulty obtaining scarce raw materials and supplies; resource constraints, including human capital and manufacturing capacity, on the ability of Novavax to pursue planned regulatory pathways; challenges meeting contractual requirements under agreements with multiple commercial, governmental, and other entities; and those other risk factors identified in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Novavax' Annual Report on Form 10-K for the year ended&#160;December 31, 2020&#160;and subsequent Quarterly Reports on Form 10-Q, as filed with the Securities and Exchange Commission (SEC). We caution investors not to place considerable reliance on forward-looking statements contained in this press release. You are encouraged to read our filings with the SEC, available at&#160;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=2144051270&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3418278-1%26h%3D306882685%26u%3Dhttp%253A%252F%252Fwww.sec.gov%252F%26a%3Dwww.sec.gov&amp;a=www.sec.gov" target="_blank" rel="nofollow">www.sec.gov</a>&#160;and&#160;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=2094473873&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3418278-1%26h%3D393278701%26u%3Dhttp%253A%252F%252Fwww.novavax.com%252F%26a%3Dwww.novavax.com&amp;a=www.novavax.com" target="_blank" rel="nofollow">www.novavax.com</a>, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document, and we undertake no obligation to update or revise any of the statements. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.</p>
<p><b>Contacts:</b></p>
<p><u>Investors <br></u>Novavax, Inc. <br><span class="xn-person">Erika Schultz</span> | 240-268-2022 <br><a href="mailto:ir@novavax.com" target="_blank" rel="nofollow">ir@novavax.com</a></p>
<p>Solebury Trout <br><span class="xn-person">Alexandra Roy</span> | 617-221-9197 <br><a href="mailto:aroy@soleburytrout.com" target="_blank" rel="nofollow">aroy@soleburytrout.com</a></p>
<p><u>Media <br></u><span class="xn-person">Ali Chartan</span> | 240-720-7804 <br><span class="xn-person">Laura Keenan Lindsey</span> | 202-709-7521 <br><a href="mailto:media@novavax.com" target="_blank" rel="nofollow">media@novavax.com</a></p>
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1551"><p><a href="https://mma.prnewswire.com/media/1506866/Novavax_High_Res_Logo.html" target="_blank" rel="nofollow"><img src="https://mma.prnewswire.com/media/1506866/Novavax_High_Res_Logo.jpg" title="Novavax Logo (PRNewsfoto/Novavax)" alt="Novavax Logo (PRNewsfoto/Novavax)"></a></p>
</div><p>&#160;</p>

<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder0">
</div>

<p>SOURCE  Novavax, Inc.</p>
<img alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=PH47280&amp;Transmission_Id=202201311342PR_NEWS_USPR_____PH47280&amp;DateId=20220131" style="border:0px; width:1px; height:1px;"></div>




<div class="wd_toolbar wd_toolbar-detail"><ul class="wd_tools"><li class="wd_tool wd_tool-print"><span class="wd_tool_icon"><a onclick="view_printable(); return false;" rel="nofollow" href="#print" title="print"><span class="fa fa-print"></span></a></span></li><li class="wd_tool wd_tool-socialshare_facebook"><span class="wd_tool_icon">
                    <a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fir.novavax.com%2Findex.php%3Fs%3D43%26item%3D338" target="_blank" title="Facebook Share" style="background-color:#4267B2;">
                    <span class="fa fa-facebook"></span>
                    </a>
                </span></li><li class="wd_tool wd_tool-socialshare_linkedin"><span class="wd_tool_icon">
                    <a href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https%3A%2F%2Fir.novavax.com%2Findex.php%3Fs%3D43%26item%3D338" target="_blank" title="Linkedin Share" style="background-color:#0077B5;">
                    <span class="fa fa-linkedin"></span>
                    </a>
                </span></li><li class="wd_tool wd_tool-socialshare_twitter"><span class="wd_tool_icon">
                    <a href="https://twitter.com/share?url=https%3A%2F%2Fir.novavax.com%2Findex.php%3Fs%3D43%26item%3D338" target="_blank" title="Twitter Share" style="background-color:#1DA1F2;">
                    <span class="fa fa-twitter"></span>
                    </a>
                </span></li><li class="wd_tool wd_tool-email"><span class="wd_tool_icon"><a onclick="window.location.href = 'mailto:?subject=Novavax%20Submits%20Request%20to%20the%20U.S.%20FDA%20for%20Emergency%20Use%20Authorization%20of%20COVID-19%20Vaccine%20-%20Jan%2031%2C%202022&amp;body='+encodeURIComponent(window.location.href);return false;" href="#email" title="email"><span class="fa fa-envelope"></span></a></span></li><li class="wd_tool wd_tool-rss"><span class="wd_tool_icon"><a href="https://ir.novavax.com/index.php?s=95&amp;rsspage=43" title="rss"><span class="fa fa-rss"></span></a></span></li><li class="wd_tool wd_tool-pdf"><span class="wd_tool_icon"><a href="https://ir.novavax.com/2022-01-31-Novavax-Submits-Request-to-the-U-S-FDA-for-Emergency-Use-Authorization-of-COVID-19-Vaccine?sf159335945=1&amp;asPDF=1" rel="nofollow" title="pdf"><span class="fa fa-file-pdf-o"></span></a></span></li></ul></div>

<!-- ITEMDATE: 2022-01-31 13:42:00 EST -->

</div>
</div>  		</div>
    
    </div>
    <!-- END CONTENT -->
  </div></div>    
  
  
      
        
  </div>

  </div>
</article>

          </div>
  </div>
<style>.edit__action{padding: 0 5px;}</style>
<div id="block-sitefooterblock" class="block block-nvaxcom-app block-site-footer">
      
    
      <div class="content">
  <footer class="oc-footer act-component jsPopupContainer">
    <div class="oc-footer__rgnInner act-component-inner">
      <div class="oc-footer__rgnTop">
        <div class="oc-footer__rgnLogo">
          <a href="https://www.novavax.com/home">              <div class="oc-footer__logo"><img src="images/novavax-footer-logo.svg" alt="Novavax Logo" class="af-image"></div>    

            </a>        </div>

        <div class="oc-footer__rgnMain row">
                                                  <div class="oc-footer__rgnSection col-lg-2 col-md-4 col-sm-12">
                  <div class="oc-footer__sectionIcon"><img src="images/Icon_Science_Technology.svg" alt="footer section icon" class="af-image"></div>    

                  <div class="oc-footer__sectionTitle"><div class="af-text">Science &amp; technology</div></div>    

                      

                                                  <ul class="oc-footer__sectionNav">
                                          <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavax.com/science-technology" aria-label="Overview">Overview</a></div>    
</li>
                                            <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavax.com/science-technology/vaccine-pipeline" aria-label="Our pipeline">Our pipeline</a></div>    
</li>
                                            <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology" aria-label="Recombinant nanoparticle vaccine technology">Recombinant nanoparticle vaccine technology</a></div>    
</li>
                                            <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavax.com/science-technology/matrix-m-adjuvant-technology" aria-label="Matrix-M&#8482; adjuvant technology">Matrix-M&#8482; adjuvant technology</a></div>    
</li>
                                            <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavax.com/global-vaccine-approval-authorization-map" aria-label="Global vaccine authorization/approval map">Global vaccine authorization/approval map</a></div>    
</li>
                                        </ul>
                                              </div>
                                        <div class="oc-footer__rgnSection col-lg-2 col-md-4 col-sm-12">
                  <div class="oc-footer__sectionIcon"><img src="images/Icon_Who_We_Are.svg" alt="footer section icon" class="af-image"></div>    

                  <div class="oc-footer__sectionTitle"><div class="af-text">Who we are</div></div>    

                      

                                                  <ul class="oc-footer__sectionNav">
                                          <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavax.com/who-we-are" aria-label="Our company">Our company</a></div>    
</li>
                                          <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavax.com/who-we-are/leadership#executive-leadership" aria-label="Executive leadership">Executive leadership</a></div>    
</li>
                                            <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavax.com/who-we-are/leadership#senior-management-team" aria-label="Senior management team">Senior management team</a></div>    
</li>
                                            <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavax.com/who-we-are/leadership#board-of-directors" aria-label="Board of directors">Board of directors</a></div>    
</li>
                                            <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavax.com/who-we-are/partners" aria-label="Our partners">Our partners</a></div>    
</li>
                                        </ul>
                                              </div>
                                        <div class="oc-footer__rgnSection col-lg-2 col-md-4 col-sm-12">
                  <div class="oc-footer__sectionIcon"><img src="images/Icon_More_Information.svg" alt="footer section icon" class="af-image"></div>    

                  <div class="oc-footer__sectionTitle"><div class="af-text">More information</div></div>    

                      

                                                  <ul class="oc-footer__sectionNav">
                                          <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavaxcovidvaccine.com" aria-label="Global authorization site of Novavax COVID-19 Vaccine (recombinant, adjuvanted)" target="_blank" rel="noopener">Global authorization site of Novavax COVID-19 Vaccine (recombinant, adjuvanted)</a></div>    
</li>
                                            <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavaxmedinfo.com" aria-label="Global medical information site" target="_blank" rel="noopener">Global medical information site</a></div>    
</li>
                                            <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavaxmedinfo.com" aria-label="Ask medical questions, report adverse events, and product  quality complaints" target="_blank" rel="noopener">Ask medical questions, report adverse events, and product  quality complaints</a></div>    
</li>
                                        </ul>
                                              </div>
                                        <div class="oc-footer__rgnSection col-lg-2 col-md-4 col-sm-12">
                  <div class="oc-footer__sectionIcon"><img src="images/Icon_Contact_Us.svg" alt="footer section icon" class="af-image"></div>    

                  <div class="oc-footer__sectionTitle"><div class="af-text">Contact us</div></div>    

                      

                                                  <ul class="oc-footer__sectionNav">
                                          <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://www.novavax.com/contact-us" aria-label="Connect with us">Connect with us</a></div>    
</li>
                                            <li class="oc-footer__navItem">      <div class="oc-footer__navLink"><a class="af-link" href="https://ir.novavax.com/join-press-release-list" aria-label="Sign up for updates">Sign up for updates</a></div>    
</li>
                                        </ul>
                                                  <ul class="oc-footer__rgnSocial">
                                          <li class="oc-footer__socialLink"><a class="af-link" href="https://www.linkedin.com/company/novavax/" aria-label="Linkedin" target="_blank" rel="noopener"><i class="fab fa-linkedin-in"></i></a></li>
                                              <li class="oc-footer__socialLink"><a class="af-link" href="https://twitter.com/Novavax" aria-label="Twitter" target="_blank" rel="noopener"><i class="fab fa-twitter"></i></a></li>
                                              <li class="oc-footer__socialLink"><a class="af-link" href="https://www.youtube.com/c/Novavax" aria-label="YouTube" target="_blank" rel="noopener"><i class="fab fa-youtube"></i></a></li>
                                              <li class="oc-footer__socialLink"><a class="af-link" href="https://www.facebook.com/Novavax/" aria-label="Facebook" target="_blank" rel="noopener"><i class="fab fa-facebook-f"></i></a></li>
                                          </ul>
                              </div>
                                        <div class="oc-footer__rgnSection col-lg-3 col-md-4 col-sm-12">
                  <div class="oc-footer__sectionIcon"><img src="images/Icon_Careers.svg" alt="footer section icon" class="af-image"></div>    

                  <div class="oc-footer__sectionTitle"><div class="af-text">Careers</div></div>    

                  <div class="oc-footer__sectionDesc"><div class="af-text"><p><span class="s-circle">235</span><a href="https://www.novavax.com/careers">Current opportunities</a></p><p>Novavax is proud to be recognized by the 2021 Top Workplaces USA, reflecting our dedication to an exceptional work culture</p><p>Explore current opportunities in:</p></div></div>    

                                  <ul class="oc-footer__rgnFlags">
                                                                  <li class="oc-footer__flagItem">
                          <a href="https://recruiting.ultipro.com/NOV1010NOVX/JobBoard/155a724f-791e-4459-a8af-da4dfe835524/?q=&amp;o=postedDateDesc&amp;f4=aSrdoB2_Q025zA4Pe4Yk_w%20bKvzmivc0FO0geD2r6Ll-A%20r-_1K1qpNFSMeCTX50naMQ%20wqyxa34abVy4ytrOmgbIHw%20OG4GK90Zfl2U3y4jSgprqg%2079wETBFC-l2DDN5y7G0nWQ" target="_blank" class="" rel="noopener">
                                                          <div class="oc-footer__flagIcon"><img src="images/us.svg" alt="" class="af-image"></div>    

                                                          <div class="oc-footer__flagTitle"><div class="af-text">USA</div></div>    

                          </a>
                        </li>
                                                                                        <li class="oc-footer__flagItem">
                          <a href="https://www.novavax.cz/en/career/" target="_blank" class="" rel="noopener">
                                                          <div class="oc-footer__flagIcon"><img src="images/cz.svg" alt="" class="af-image"></div>    

                                                          <div class="oc-footer__flagTitle"><div class="af-text">CZ</div></div>    

                          </a>
                        </li>
                                                                                        <li class="oc-footer__flagItem">
                          <a href="https://www.jobbet.se/pagaende-rekryteringar/novavax-ab/kemikalieansvarig/cketqasv2mje20736w0tvxel7" target="_blank" class="" rel="noopener">
                                                          <div class="oc-footer__flagIcon"><img src="images/se.svg" alt="" class="af-image"></div>    

                                                          <div class="oc-footer__flagTitle"><div class="af-text">SE</div></div>    

                          </a>
                        </li>
                                                                                        <li class="oc-footer__flagItem">
                          <a href="https://recruiting.ultipro.com/NOV1010NOVX/JobBoard/155a724f-791e-4459-a8af-da4dfe835524/?q=&amp;o=postedDateDesc&amp;f4=NqaZ9xyNTV-wX4-fL8LFFg%20b9mmns9Hv0676Tjc23TrCQ%20h7LB7pN0Flywo6wtJGwmyQ%20f46k0GSoAVSKDrZlqF5gRw" target="_blank" class="" rel="noopener">
                                                          <div class="oc-footer__flagIcon"><img src="images/eu.svg" alt="" class="af-image"></div>    

                                                          <div class="oc-footer__flagTitle"><div class="af-text">EUR</div></div>    

                          </a>
                        </li>
                                                                                        <li class="oc-footer__flagItem">
                          <a href="https://recruiting.ultipro.com/NOV1010NOVX/JobBoard/155a724f-791e-4459-a8af-da4dfe835524/?q=&amp;o=postedDateDesc&amp;f4=V-wueBOBE0yt7aOM8ZkTaw" target="_blank" class="" rel="noopener">
                                                          <div class="oc-footer__flagIcon"><img src="images/apac.svg" alt="" class="af-image"></div>    

                                                          <div class="oc-footer__flagTitle"><div class="af-text">APAC</div></div>    

                          </a>
                        </li>
                                                            </ul>
                                                              </div>
                                  <div class="oc-footer__sideImage col-lg-1 col-md-4 col-sm-12"><img src="images/TopPlacesResized.png" alt="top work place 2021 logo" class="af-image"></div>    

        </div>


      </div>
      <div class="oc-footer__rgnBottom d-block">
        <div class="oc-footer__rgnBottomInner">
            <div class="oc-footer__copyright"><div class="af-text">&#169; 2023 Novavax. All rights reserved.</div></div>    

                      <ul class="oc-footer__rgnBottomNav">
                              <li class="oc-footer__bottomItem">      <div class="oc-footer__bottomLink"><a class="af-link" href="https://www.novavax.com/privacy-policy" aria-label="Privacy Policy">Privacy Policy</a></div>    
</li>
                                <li class="oc-footer__bottomItem">      <div class="oc-footer__bottomLink"><a class="af-link" href="https://www.novavax.com/cookies-policy" aria-label="Cookies Policy">Cookies Policy</a></div>    
</li>
                                <li class="oc-footer__bottomItem">      <div class="oc-footer__bottomLink"><a class="af-link" href="https://www.novavax.com/terms-conditions" aria-label="Terms and Conditions">Terms and Conditions</a></div>    
</li>
                                <li class="oc-footer__bottomItem">      <div class="oc-footer__bottomLink"><a class="af-link" href="https://www.novavax.com/sitemap" aria-label="Site Map">Site Map</a></div>    
</li>
                                <li class="oc-footer__bottomItem">      <div class="oc-footer__bottomLink"><a class="af-link" href="https://novavax.widen.net/s/r28zg5tbjw/ofccp_pay_transparency_nondiscrimination_provision" aria-label="Pay Transparency Nondiscrimination Provision" target="_blank" rel="noopener">Pay Transparency Nondiscrimination Provision</a></div>    
</li>
                                <li class="oc-footer__bottomItem">      <div class="oc-footer__bottomLink"><a class="af-link" href="https://novavax.widen.net/s/dhzs9jd2gb/nvax-po-language_20210607" aria-label="Purchase Order Terms and Conditions" target="_blank" rel="noopener">Purchase Order Terms and Conditions</a></div>    
</li>
                            </ul>
                  </div>

      </div>
    </div>

                        <!-- Modal -->
  <div class="modal fade media-lightbox -redirect jsExtRedirect" tabindex="-1" role="dialog" aria-hidden="true" id="jtEIf3">
    <div class="modal-dialog modal-dialog-centered" role="document">
      <div class="modal-content">
        <div class="modal-header">
          <button type="button" class="close" data-dismiss="modal" aria-label="Close">
            <span aria-hidden="true"><i class="fal fa-times"></i></span>
          </button>
        </div>
        <div class="modal-body">
            <div class="modal-body__title"><div class="af-text">You are leaving novavax.com</div></div>    

            <div class="modal-body__summary"><div class="af-text"><p>You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Novavax provides this link as a service to website visitors. Novavax is not responsible for the privacy policy of any third-party websites.</p></div></div>    

          <div class="modal-body__rgnActions">
            <div class="modal-body__actionButton"><a class="jsPopRedirect" href="#">Continue</a></div>
            <div class="modal-body__actionButton"><a class="jsPopCancel" href="#">Cancel</a></div>
          </div>
        </div>
      </div>
    </div>
  </div>  

                    <!-- Modal -->
  <div class="modal fade media-lightbox -redirect jsMedicalRedirect" tabindex="-1" role="dialog" aria-hidden="true" id="ufgsQO">
    <div class="modal-dialog modal-dialog-centered" role="document">
      <div class="modal-content">
        <div class="modal-header">
          <button type="button" class="close" data-dismiss="modal" aria-label="Close">
            <span aria-hidden="true"><i class="fal fa-times"></i></span>
          </button>
        </div>
        <div class="modal-body">
            <div class="modal-body__title"><div class="af-text">This Novavax website is for US medical professionals only.</div></div>    

            <div class="modal-body__summary"><div class="af-text"><p>Click "Continue" only if you are a US medical professional.</p></div></div>    

          <div class="modal-body__rgnActions">
            <div class="modal-body__actionButton"><a class="jsPopRedirect" href="#">Continue</a></div>
            <div class="modal-body__actionButton"><a class="jsPopCancel" href="#">Cancel</a></div>
          </div>
        </div>
      </div>
    </div>
  </div>  

                  

  </footer>
      
      

          </div>
  </div>


                </section>
              </main>
                                  </div>
        </div>
          </div>
        <footer class="site-footer">
              <div class="container">
                            </div>
          </footer>
  </div>
</div>

  </div>

    
    <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","scriptPath":null,"pathPrefix":"","currentPath":"node\/296","currentPathIsAdmin":false,"isFront":true,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"act_bootstrap\/base,act_bootstrap\/theme,act_layout\/layout_bootstrap,act_layout\/off_canvas_override,bootstrap_barrio\/global-styling,bootstrap_barrio\/node,eu_cookie_compliance\/eu_cookie_compliance_default,extlink\/drupal.extlink,nvaxcom_bootstrap\/nvaxcom-app,system\/base","theme":"nvaxcom_bootstrap","theme_token":null},"ajaxTrustedUrl":[],"data":{"extlink":{"extTarget":true,"extTargetNoOverride":false,"extNofollow":false,"extNoreferrer":false,"extFollowNoOverride":false,"extClass":"0","extLabel":"(link is external)","extImgClass":false,"extSubdomains":true,"extExclude":"","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":false,"extAlertText":"This link will take you to an external web site. We are not responsible for their content.","mailtoClass":"0","mailtoLabel":"(link sends email)","extUseFontAwesome":false,"extIconPlacement":"append","extFaLinkClasses":"fa fa-external-link","extFaMailtoClasses":"fa fa-envelope-o","whitelistedDomains":null}},"eu_cookie_compliance":{"cookie_policy_version":"1.0.0","popup_enabled":false,"popup_agreed_enabled":false,"popup_hide_agreed":false,"popup_clicking_confirmation":true,"popup_scrolling_confirmation":false,"popup_html_info":false,"use_mobile_message":false,"mobile_popup_html_info":false,"mobile_breakpoint":768,"popup_html_agreed":false,"popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/","popup_link_new_window":true,"popup_position":false,"fixed_top_position":true,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":false,"cookie_name":"","reload_page":false,"domain":"","domain_all_sites":false,"popup_eu_only_js":false,"cookie_lifetime":100,"cookie_session":0,"set_cookie_session_zero_on_disagree":0,"disagree_do_not_show_popup":false,"method":"default","automatic_cookies_removal":true,"allowed_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv role=\u0022alertdialog\u0022 aria-labelledby=\u0022popup-text\u0022 class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info eu-cookie-compliance-content\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022 class=\u0022eu-cookie-compliance-message\u0022\u003E\n      \u003Ch2\u003EWe use cookies on this site to enhance your user experience\u003C\/h2\u003E\u003Cp\u003EYou have given your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022 class=\u0022eu-cookie-compliance-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","withdraw_enabled":false,"reload_options":0,"reload_routes_list":"","withdraw_button_on_info_popup":false,"cookie_categories":[],"cookie_categories_details":[],"enable_save_preferences_button":true,"cookie_value_disagreed":"0","cookie_value_agreed_show_thank_you":"1","cookie_value_agreed":"2","containing_element":"body","settings_tab_enabled":false,"open_by_default":false},"user":{"uid":0,"permissionsHash":"8b3dc20e10a20262ffcc6941c1d54fa61f0c4bb84c80cf8497730cd27303f32e"}}</script>
<script src="js/js_tIET3UQ_hBz4lJcBYaPnjg2NQYpxaDRVlI45EliNr7k.js"></script>
<script src="js/js_lS32cxviPvF9na_3r4akSaMyl0daYeUrDCvkjdpA4OI.js"></script>
<script src="js/eu_cookie_compliance.js" defer></script>
<script type="text/javascript">
	$(document).ready(function() {
		// scroll nav to active item on mobile
		$(window).resize(function() {
			if($(window).width() < 768 && $('.oc-tabContainer__rgnTabs.wd_nav').find('a.active').length) {
				$('.oc-tabContainer__rgnTabs.wd_nav').animate({scrollLeft: $('.oc-tabContainer__rgnTabs.wd_nav a.active').position().left}, 500);
			}
		}).resize();

    if($('.wd_featureboxes_stocktop').length) {
      setTimeout(function() {
          $('.wd_featureboxes_stocktop .wd_quote-price, .wd_featureboxes_stock .wd_widget .wd_price span').append(' USD');
          $('.wd_featureboxes_stocktop .wd_chart-quote-footer').html($('.wd_featureboxes_stocktop .wd_chart-quote-footer').html().split('<br>')[1]);
      }, 2000);

      $('.wd_featureboxes_stocktop .wd_featurebox').after('<div class="wd_arrow_link"><a href="https://ir.novavax.com/stock-details">Stock details</a></div>');
    }

    $('.wd_featureboxes_top .wd_featurebox_container').each(function() {
      var title = $(this).find('.wd_featurebox_title').text();
      $(this).find('.wd_attachment a').attr('aria-label', title);
    })

    $('.wd_featureboxes_middlecallout1 .wd_featurebox_container').each(function() {
      $(this).find('.wd_whyinvest_container1').prepend($(this).find('.wd_featurebox_title'));
    })
    // $('.wd_featureboxes_middlecallout1 .wd_whyinvest_container1').prepend($('.wd_featureboxes_middlecallout1 .wd_featurebox_title'));

    $('.wd_featureboxes_bottom .wd_featurebox_container').each(function() {
      $(this).find('.wd_imagetable').nextAll().wrapAll('<div class="wd_featureboxes_content"></div>');
      $(this).find('.wd_featureboxes_content').prepend($(this).find('.wd_featurebox_title'));
    })

          $('.wd_newsfeed_releases .wd_item:nth-child(odd)').each(function() {
        $(this).next().addBack().wrapAll('<ul class="wd_row"></ul>');
      })
      // $('.wd_pageid_43.wd_item_page .wd_newsfeed_releases-header .page_header').html($('.wd_newsfeed_releases-detail .wd_title').html());

      $('.wd_newsfeed_releases-detail .wd_asset_inline_list').parents('div[wd_move_after]').addClass('wd_inline-wrapper');
              $('.page_header').html($('.wd_title').html());
      $('.wd_pageid_19.wd_item_page #wd_printable_content').wrap('<div class="oc-container__rgnInner"></div>');
    
        
    
    // Responsive tables
    $('table.responsive.wd_table_row').each(function() {
        var head_col_count =  $(this).find('thead th').length;
        var i;
        for ( i=0; i <= head_col_count; i++ )  {
            var head_col_label = $(this).find('th:nth-child('+ i +')').text();
            if (head_col_label != ""){
                head_col_label = head_col_label + "";
            }
            $(this).find('tr td:nth-child('+ i +')').attr('data-th',head_col_label);
        }
    });

    // Custom dropdowns
    $('.wd_search_basic_fields select').each(function() {
      var name = $(this).attr('name');
      $(this).wrap('<div data-name="'+name+'" class="wd_custom_select ac-dropmenu__rgnDropdown dropdown"></div>').before('<button class="ac-dropmenu__trigger dropdown-toggle" type="button" data-toggle="dropdown" aria-expanded="false" aria-haspopup="true"></button>');
      $(this).siblings('button.dropdown-toggle').text($(this).find(':selected').text());
      var options = '';
      var value;
      var label;
      $(this).find('option').each(function() {
        value = $(this).attr('value');
        label = $(this).text();
        options += '<div class="ac-dropmenu__menuItem dropdown-item"><a class="af-link" href="#" data-value="'+value+'"" aria-label="'+label+'">'+label+'</a></div>';
      })
      $(this).after('<div class="ac-dropmenu__menu dropdown-menu">'+options+'</div>');
    })

    $('.wd_custom_select .dropdown-item a').click(function(e) {
      e.preventDefault();
      var value = $(this).attr('data-value');
      $(this).parents('.wd_custom_select').find('select option[value="'+value+'"]').parent().val(value);
      $(this).parents('.wd_custom_select').find('button.dropdown-toggle').text($(this).text());
    })
    $('.wd_pageid_43 label[for="item_basic_search_43_category"]').removeClass('wd_sr-only').prependTo('.wd_search_basic_fields .wd_custom_select[data-name="category"]');

    $('.wd_events_inputs select').wrap('<div class="wd_events_select-wrapper"><div class="wd_events_select"></div></div>');
    $('#wd_events_input_year').parent().before('<label for="wd_events_input_year">Year</label>');
    $('#wd_events_input_month').parent().before('<label for="wd_events_input_month">Month</label>');
    $('#wd_events_input_category').parent().before('<label for="wd_events_input_category">Category</label>');

    
    $('h4.wd_historical_calendar-label').html('Select A date');

    $('.wd_events-detail .wd_event_info .wd_event_cta').insertAfter('.wd_event-buttons');

    	}) // end ready
</script>

<script src="js/wd_scripts.js"></script>


<!-- begin spin_special_output(body_end) -->
<script wd_script_id="piwik_tracking_code"></script>
<!-- Piwik Tracking Code -->
<script type="text/javascript">
  var _paq = _paq || [];

  _paq.push(["setCustomVariable", 4, "News Release Feed ID", "202201311342PR_NEWS_USPR_____PH47280", "page"]);

  _paq.push(["setCustomVariable", 1, "Content Type", "News Releases Feed", "page"]);

  _paq.push(["setCustomVariable", 3, "Navigation Page", "Latest press releases : Press releases & statements", "page"]);

  _paq.push(["trackPageView"]);
  _paq.push(["enableLinkTracking"]);
  (function() {
    var u="//stats.drivetheweb.com/";
    _paq.push(["setTrackerUrl", u+"piwik.php"]);
    _paq.push(["setSiteId", 6545]);
    var d=document, g=d.createElement("script"), s=d.getElementsByTagName("script")[0];
    g.type="text/javascript"; g.async=true; g.defer=true; g.src=u+"piwik.js"; s.parentNode.insertBefore(g,s);
  })();
</script>
<noscript>
	<img src="https://stats.drivetheweb.com/piwik.php?idsite=6545&amp;rec=1" style="border:0" alt="">
</noscript>
<!-- End Piwik Tracking Code -->
		
<!-- end spin_special_output(body_end) -->
</body></html>